×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

  • Gurus
  • Event Driven
  • RANGELEY CAPITAL, LLC (Data extracted from 13F, 13D, 13G and Form 4)

RANGELEY CAPITAL, LLC

AUM: $196.94 M
13-F Portfolio Value: $115.57 M
Last 13-F Filed: Q3 2025
Concentration in top 10: 41.83%
Filter by:
Quarter to View:
Stock Company % Portfolio Shares Held Market Value Change in Shares % Change Quarter End Price Source
AKYAAKOYA BIOSCIENCES INC-33,035Exited13F
BPMCBLUEPRINT MEDICINES CORP-5,000Exited13F
CRGXCARGO THERAPEUTICS INC-41,851Exited13F
ELEVELEVATION ONCOLOGY INC-905,289Exited13F
EPIXESSA PHARMA INC-170,000Exited13F
HLVXHILLEVAX INC-153,790Exited13F
ITOSITEOS THERAPEUTICS INC-302,080Exited13F
MEIPMEI PHARMA INC-10,000Exited13F
NBYNOVABAY PHARMACEUTICALS INC-33,210Exited13F
NUVBNUVATION BIO INC-13,000Exited13F
SAGESAGE THERAPEUTICS INC-730,000Exited13F
SKXSKECHERS U S A INC-36,000Exited13F
SYBXSYNLOGIC INC-13,597Exited13F
THTXTHERATECHNOLOGIES INC-50,000Exited13F
THRDTHIRD HARMONIC BIO INC-290,000Exited13F
VERVVERVE THERAPEUTICS INC-62,000Exited13F
VIGLVIGIL NEUROSCIENCE INC-67,800Exited13F
SEATVIVID SEATS INC-25,000Exited13F
WBAWALGREENS BOOTS ALLIANCE INC-102,000Exited13F
WOWWIDEOPENWEST INC (Call)-50,000Exited13F
AACTARES ACQUISITION CORP II-11,920Exited13F
MLACRMOUNTAIN LAKE ACQUISITION CO-30,000Exited13F
TBPHTHERAVANCE BIOPHARMA INC-33,729Exited13F
ZURAZURA BIO LTD-21,000Exited13F